Marker Therapeutics (MRKR) Short Interest Ratio & Short Volume $1.19 -0.04 (-3.25%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.20 +0.02 (+1.26%) As of 08/8/2025 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Marker Therapeutics Short Interest DataMarker Therapeutics (MRKR) has a short interest of 103,100 shares, representing 1.31% of the float (the number of shares available for trading by the public). This marks a -15.97% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 3.47 million shares to cover all short positions.Current Short Interest103,100 sharesPrevious Short Interest122,700 sharesChange Vs. Previous Month-15.97%Dollar Volume Sold Short$161.87 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares11,310,000 sharesFloat Size7,900,000 sharesShort Percent of Float1.31%Today's Trading Volume82,321 sharesAverage Trading Volume3,469,700 sharesToday's Volume Vs. Average2% Short Selling Marker Therapeutics? Sign up to receive the latest short interest report for Marker Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMRKR Short Interest Over TimeMRKR Days to Cover Over TimeMRKR Percentage of Float Shorted Over Time Marker Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025103,100 shares $161.87 thousand -16.0%1.3%0.1 $1.57 6/30/2025122,700 shares $187.73 thousand -29.2%1.6%1.1 $1.53 6/15/2025173,300 shares $277.28 thousand +46.0%2.2%1.7 $1.60 5/31/2025118,700 shares $184.01 thousand -6.5%1.5%1.1 $1.55 5/15/2025127,000 shares $143.51 thousand +0.2%1.6%1.2 $1.13 4/30/2025126,700 shares $150.77 thousand -35.8%1.6%1.1 $1.19 4/15/2025197,200 shares $230.72 thousand -50.7%2.6%1.6 $1.17 3/31/2025400,000 shares $492 thousand +7.4%5.4%3.1 $1.23 3/15/2025372,500 shares $460.04 thousand +170.1%5.0%2.9 $1.24 2/28/2025137,900 shares $210.99 thousand -7.9%1.9%1 $1.53 Get the Latest News and Ratings for MRKR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2025149,800 shares $257.66 thousand -35.5%2.1%1.9 $1.72 1/31/2025232,100 shares $427.06 thousand +20.0%3.0%3.2 $1.84 1/15/2025193,400 shares $531.85 thousand +74.6%2.5%3.1 $2.75 12/31/2024110,800 shares $344.59 thousand +32.5%1.6%1.8 $3.11 12/15/202483,600 shares $340.25 thousand +66.9%1.3%1.5 $4.07 11/30/202450,100 shares $175.35 thousand -12.1%0.8%1.4 $3.50 11/15/202457,000 shares $174.99 thousand -18.6%0.9%1.6 $3.07 10/31/202470,000 shares $283.50 thousand +14.2%1.1%1.9 $4.05 10/15/202461,300 shares $200.45 thousand +9.9%1.0%1.7 $3.27 9/30/202455,800 shares $157.36 thousand -13.9%0.9%2.2 $2.82 9/15/202464,800 shares $179.78 thousand -22.7%1.0%2.4 $2.77 8/31/202483,800 shares $302.52 thousand +3.3%1.3%2.7 $3.61 8/15/202481,100 shares $257.90 thousand -17.8%1.3%3 $3.18 7/31/202498,600 shares $482.15 thousand -2.2%1.5%4.4 $4.89 7/15/2024100,800 shares $561.46 thousand -14.0%1.6%4.7 $5.57 6/30/2024117,200 shares $636.40 thousand +25.6%1.8%5.9 $5.43 6/15/202493,300 shares $388.57 thousand +58.1%1.5%4.6 $4.16 5/31/202459,000 shares $228.33 thousand +17.1%0.9%3.5 $3.87 5/15/202450,400 shares $210.17 thousand -6.5%0.8%3 $4.17 4/30/202453,900 shares $218.30 thousand -16.3%0.8%3 $4.05 4/15/202464,400 shares $285.94 thousand -40.3%1.0%3.4 $4.44 3/31/2024107,900 shares $463.97 thousand -27.9%1.7%5.1 $4.30 3/15/2024149,700 shares $663.17 thousand -7.0%2.3%6 $4.43 2/29/2024160,900 shares $584.07 thousand -9.6%2.5%2 $3.63 2/15/2024177,900 shares $752.52 thousand +1.1%2.8%2.2 $4.23 1/31/2024175,900 shares $816.18 thousand -12.7%2.7%2.2 $4.64 1/15/2024201,400 shares $970.75 thousand -14.5%3.1%2.5 $4.82 12/31/2023235,500 shares $1.30 million -10.9%3.7%2.9 $5.50 12/15/2023264,300 shares $1.24 million +56.0%4.1%3.3 $4.70 11/30/2023169,400 shares $467.54 thousand -18.1%2.7%2.3 $2.76The Coin That Could Define Trump’s Crypto Presidency (Ad)When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”Discover the coin that could define Trump’s crypto presidency. 11/15/2023206,900 shares $577.25 thousand -3.9%3.2%5.6 $2.79 10/31/2023215,200 shares $516.48 thousand -7.8%3.4%4.6 $2.40 10/15/2023233,400 shares $772.55 thousand -10.0%3.7%2.7 $3.31 9/30/2023259,200 shares $1.18 million -16.5%4.1%2.2 $4.54 9/15/2023310,300 shares $1.66 million +65.8%4.9%2.2 $5.36 8/31/2023187,200 shares $1.05 million -11.3%3.0%0.9 $5.62 8/15/2023211,000 shares $1.24 million -23.1%3.3%0.3 $5.86 7/31/2023274,200 shares $1.38 million +43.3%4.4%0.3 $5.05 7/15/2023191,300 shares $1.01 million -41.1%3.0%0.2 $5.26 6/30/2023325,000 shares $1.01 million -28.8%5.2%0.4 $3.10 6/15/2023456,500 shares $1.13 million +478.6%7.2%0.6 $2.48 5/31/202378,900 shares $140.44 thousand -26.3%1.3%0.1 $1.78 5/15/2023107,000 shares $146.59 thousand -51.0%1.7%0.8 $1.37 4/30/2023218,400 shares $183.76 thousand +1,169.8%3.0%1.6 $0.84 4/15/202317,200 shares $18.92 thousand +91.1%0.2%0.2 $1.10 3/31/20239,000 shares $6.39 thousand -90.0%0.1%0.2 $0.71 3/15/202389,900 shares $178.00 thousand +37.5%1.2%1.7 $1.98 2/28/202365,400 shares $141.92 thousand +64.3%0.9%1.7 $2.17 2/15/202339,800 shares $89.95 thousand -18.3%0.6%1 $2.26 1/31/202348,700 shares $136.36 thousand -93.7%0.8%1.2 $2.80 1/15/2023767,400 shares $272.50 thousand +30.8%1.2%2.6 $0.36 12/30/2022586,600 shares $155.98 thousand -21.4%1.0%1.9 $0.27 12/15/2022745,800 shares $222.62 thousand -11.6%1.3%2.7 $0.30 11/30/2022843,800 shares $253.14 thousand -14.7%1.4%2.5 $0.30 11/15/2022989,100 shares $343.51 thousand -16.9%1.7%2 $0.35 10/31/20221,190,000 shares $528.00 thousand +21.5%2.0%2.2 $0.44 10/15/2022979,200 shares $381.89 thousand -16.3%1.7%0.5 $0.39 9/30/20221,170,000 shares $431.50 thousand -6.4%4.3%0.6 $0.37 9/15/20221,250,000 shares $573.13 thousand -9.4%4.6%0.6 $0.46 8/31/20221,380,000 shares $427.80 thousand -14.3%5.1%0.7 $0.31 8/15/20221,610,000 shares $643.03 thousand +87.8%5.9%0.9 $0.40 7/31/2022857,100 shares $273.41 thousand -23.5%3.1%0.5 $0.32 7/15/20221,120,000 shares $374.08 thousand +6.7%4.1%4.1 $0.33 6/30/20221,050,000 shares $346.50 thousand -13.2%3.9%3.5 $0.33 6/15/20221,210,000 shares $326.70 thousand -8.3%4.4%3.9 $0.27 5/31/20221,320,000 shares $398.64 thousand -10.2%2.3%3.9 $0.30 5/15/20221,470,000 shares $484.22 thousand No Change2.6%3.7 $0.33 4/30/20221,470,000 shares $498.33 thousand -2.7%2.6%3.2 $0.34 4/15/20221,510,000 shares $610.04 thousand +24.8%2.7%2.9 $0.40 3/31/20221,210,000 shares $532.40 thousand -42.1%2.2%1.7 $0.44 3/15/20222,090,000 shares $836 thousand +26.7%3.7%2.8 $0.40 2/28/20221,650,000 shares $620.57 thousand +3.8%2.9%2.2 $0.38 2/15/20221,590,000 shares $935.40 thousand -7.6%2.8%2.1 $0.59 1/31/20221,720,000 shares $1.04 million +84.6%3.0%2.4 $0.61 1/15/2022931,700 shares $753.09 thousand -9.5%1.7%1.4 $0.81 12/31/20211,030,000 shares $978.50 thousand +6.3%1.8%2.4 $0.95 12/15/2021968,900 shares $968.90 thousand -14.3%1.7%2.3 $1.00 11/30/20211,130,000 shares $1.33 million No Change2.0%3 $1.18 11/15/20211,130,000 shares $1.58 million -5.0%2.0%3.4 $1.40 10/29/20211,190,000 shares $1.75 million No Change2.1%2.6 $1.47Crypto Income (almost instantly) (Ad)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? Depending on when you watch this new training, crypto income could be hitting your account as early as tonight!Watch this short video 10/15/20211,190,000 shares $1.89 million -8.5%2.1%2.5 $1.59 9/30/20211,300,000 shares $2.20 million -3.7%2.3%2.6 $1.69 9/15/20211,350,000 shares $2.46 million -3.6%2.4%2.2 $1.82 8/31/20211,400,000 shares $2.77 million -3.5%2.5%1.9 $1.98 8/13/20211,450,000 shares $2.77 million -1.4%2.6%1.5 $1.91 7/30/20211,470,000 shares $3.07 million +52.3%2.6%1.3 $2.09 7/15/2021965,500 shares $2.12 million -21.5%1.7%0.7 $2.20 6/30/20211,230,000 shares $3.43 million -47.0%2.2%0.8 $2.79 6/15/20212,320,000 shares $7.48 million -2.5%4.1%1.2 $3.23 5/28/20212,380,000 shares $6.93 million -11.5%4.2%0.6 $2.91 5/14/20212,690,000 shares $5.60 million -6.9%4.8%0.7 $2.08 4/30/20212,890,000 shares $7.75 million -7.4%5.2%0.8 $2.68 4/15/20213,120,000 shares $6.61 million -5.2%5.9%0.9 $2.12 3/31/20213,290,000 shares $7.11 million -5.7%9.2%1 $2.16 3/15/20213,490,000 shares $6.77 million +7.4%9.9%1.2 $1.94 2/26/20213,250,000 shares $8.00 million -3.9%10.0%5.5 $2.46 2/12/20213,380,000 shares $10.34 million +5.3%10.4%5.9 $3.06 1/29/20213,210,000 shares $5.78 million -4.5%9.8%6 $1.80 1/15/20213,360,000 shares $7.16 million No Change10.3%7.9 $2.13 MRKR Short Interest - Frequently Asked Questions What is Marker Therapeutics' current short interest? Short interest is the volume of Marker Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 103,100 shares of MRKR short. 1.31% of Marker Therapeutics' shares are currently sold short. Learn More on Marker Therapeutics' current short interest. What is a good short interest percentage for Marker Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.31% of Marker Therapeutics' floating shares are currently sold short. Is Marker Therapeutics' short interest increasing or decreasing? Marker Therapeutics saw a decrease in short interest in July. As of July 15th, there was short interest totaling 103,100 shares, a decrease of 16.0% from the previous total of 122,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Marker Therapeutics' float size? Marker Therapeutics currently has issued a total of 11,310,000 shares. Some of Marker Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Marker Therapeutics currently has a public float of 7,900,000 shares. How does Marker Therapeutics' short interest compare to its competitors? 1.31% of Marker Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Marker Therapeutics: INmune Bio, Inc. (23.45%), Biomea Fusion, Inc. (15.71%), MiNK Therapeutics, Inc. (25.32%), InflaRx N.V. (1.47%), DURECT Corporation (2.76%), Barinthus Biotherapeutics PLC Sponsored ADR (0.08%), Cue Biopharma, Inc. (1.47%), PyroGenesis Canada Inc. (0.07%), ImmuCell Corporation (0.33%), Adlai Nortye Ltd. Sponsored ADR (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Marker Therapeutics stock? Short selling MRKR is an investing strategy that aims to generate trading profit from Marker Therapeutics as its price is falling. MRKR shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Marker Therapeutics? A short squeeze for Marker Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MRKR, which in turn drives the price of the stock up even further. How often is Marker Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRKR, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies INMB Short Squeeze BMEA Short Squeeze INKT Short Squeeze IFRX Short Squeeze DRRX Short Squeeze BRNS Short Squeeze CUE Short Squeeze PYRGF Short Squeeze ICCC Short Squeeze ANL Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRKR) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFOUR TRILLION DOLLARS!Nvidia just became the first company in history to hit a $4 trillion valuation—surpassing Apple and Microsoft....Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marker Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marker Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
